
KLOW Blend ยท 80 mg
GLOW plus KPV. The copper peptide and the two repair peptides, with an anti-inflammatory tripeptide added โ four compounds co-lyophilised at the factory into one vial. Nearly two-thirds of it, by weight, is GHK-Cu.
Includes 10ร sterile insulin syringes + 1 vial of bacteriostatic water, free with your order.
Complete your kit
For research and educational use only. Not for human or veterinary consumption.
What people consistently report:
- Skin quality โ texture, firmness, softer fine lines, breakouts and marks healing faster. Usually from week 4โ8, and it comes from the GHK-Cu share.
- Joint and soft-tissue comfort from the BPC-157 and TB-500, often within the first 2โ4 weeks
- Calmer, less reactive skin and gut โ the reason people pick KLOW over GLOW. Reports include fewer flare-ups in redness-prone skin and a settled gut. This is anecdote, not data.
- Hair โ some users credit it with thicker hair over several months; others on the same protocol see nothing
- Post-procedure recovery โ some surgeons use it in the weeks after body procedures
What KPV adds
KPV is the last three amino acids of alpha-MSH (Lys-Pro-Val). In cell studies it blocks NF-ฮบB โ one of the master switches of inflammation โ at tiny concentrations, and given orally to mice it reduced chemically induced colitis. It does not work through the melanocortin receptors, so it isn't expected to tan you or change libido the way Melanotan does.
Every KPV result that matters was oral, in mice. Injected KPV has never been studied in people.
KLOW or GLOW?
| GLOW (70 mg) | KLOW (80 mg) | |
|---|---|---|
| GHK-Cu / BPC-157 / TB-500 | 50 / 10 / 10 mg | 50 / 10 / 10 mg |
| KPV | โ | 10 mg |
| 10 clicks at 3 mL delivers | GHK-Cu 1.67 mg + 333 mcg of each | The same, plus 333 mcg KPV |
| Choose it for | Skin + recovery | Skin + recovery, when inflammation, reactive skin or gut is part of the picture |
Same click count, same doses of the three shared peptides. KLOW is GLOW with KPV on top โ nothing more, nothing less. Whether 333 mcg of injected KPV changes anything is genuinely unknown. If your goal is purely an injury, Wolverine Blend gives you more repair peptide per click, and no copper.
No trial has tested this blend โ or any two of its four components together. Each piece has its own evidence, mostly animal. The combination is a community invention.
It does not tighten loose or sagging skin. GHK-Cu works on collagen quality, not laxity. If sagging is the real problem, a laser or a surgeon is the honest answer.
It does not treat any disease. If you have IBD, rheumatoid arthritis, eczema or rosacea under treatment, this is not a substitute โ talk to your doctor before adding anything.
It does not fix a complete tear, and pain settling is not tissue healed.
It won't show you anything in two weeks. Give skin 8โ12 weeks.
Expected and normal: the solution is blue. That's the copper held inside GHK-Cu โ the peptide wraps around a copper ion, and that complex absorbs red-orange light, so you see blue. Blue means the copper is bound. It is not contamination. The dry powder can look pale blue to lilac before mixing.
Common, and more noticeable than with most peptides: stinging at the injection site, redness, and raised welts that can last a day or two. It comes from the GHK-Cu, and it's the complaint people mention most. To reduce it: let the dose reach room temperature, inject slowly, always use the full 3 mL of water, rotate sites, and favour fattier areas (flanks, lower abdomen).
Less common: drowsiness or fatigue in the first week, nausea on the first few injections, headache, bruising.
Theoretical: BPC-157 and TB-500 promote blood-vessel growth โ the same unresolved tumour question as on their own pages.
Copper: small at our protocol (see dosing), but it is injected, so it skips the gut, which normally controls how much copper gets in.
Handling: keep KLOW in its own syringe or cartridge. Never draw it into a cartridge shared with another compound.
Stop and see a doctor:
- Yellowing of the skin or eyes, dark urine, or pain under the right ribs โ copper overload hits the liver first
- Spreading redness, heat, pus or fever at an injection site
- Hives, swelling of the face or lips, or difficulty breathing
๐ Do not use if
You have Wilson's disease or any copper-handling disorder, liver disease, active or recent cancer, or you are pregnant, breastfeeding or under 18.
Draw past the line, tap out bubbles, push back to the line.
The AVERON Peptide Pen delivers 1 click = 0.01 mL. A U-100 insulin syringe delivers 1 unit = 0.01 mL. They are the same number. 20 clicks on the pen and 20 units on a syringe deliver exactly the same dose.
Maximum per injection: 100 units (1 mL)
80 mg vial + 3 mL bacteriostatic water = 26.67 mg/mL total
| Units (U-100) | Volume | GHK-Cu | BPC-157 | TB-500 | KPV |
|---|---|---|---|---|---|
| 10 | 0.10 mL | 1.67 mg | 333 mcg | 333 mcg | 333 mcg |
| 15 | 0.15 mL | 2.5 mg | 500 mcg | 500 mcg | 500 mcg |
| 20 | 0.20 mL | 3.33 mg | 667 mcg | 667 mcg | 667 mcg |
The ratio is fixed at 5:1:1:1 by the manufacturer โ every draw delivers all four in proportion.
About the lab report: the batch in stock tested at GHK-Cu 63.47 mg, BPC-157 11.00 mg, TB-500 10.87 mg and KPV 11.77 mg. The repair peptides and KPV are 9โ18% above label. The GHK-Cu is about 27% over. In practice, each draw from this batch delivers:
| Units (U-100) | GHK-Cu | BPC-157 | TB-500 | KPV |
|---|---|---|---|---|
| 10 | 2.1 mg | 367 mcg | 362 mcg | 392 mcg |
| 15 | 3.2 mg | 550 mcg | 544 mcg | 588 mcg |
| 20 | 4.2 mg | 733 mcg | 725 mcg | 785 mcg |
That overfill is the main reason we publish 10 clicks and not more โ see dosing.
Always use the full 3 mL. Less water makes a stronger, more stinging solution, and the vial won't hold more. Inject the water slowly down the inside wall, swirl gently, never shake. Expect blue straight away.
Draw past the line, tap out bubbles, push back to the line.
The AVERON Peptide Pen delivers 1 click = 0.01 mL. A U-100 insulin syringe delivers 1 unit = 0.01 mL. They are the same number. 20 clicks on the pen and 20 units on a syringe deliver exactly the same dose.
Maximum per injection: 100 units (1 mL)
10 clicks once daily, subcutaneous. Abdomen, flanks or thigh, rotating sites.
| Weeks | Units (U-100) | Frequency | Vial |
|---|---|---|---|
| 1โ4 | 10 | Daily | Vial 1 |
| 5โ8 | 10 | Daily | Vial 2 |
| 9โ12 (optional) | 10 | Daily | Vial 3 |
Cycle: 8 weeks, up to 12, then 4โ8 weeks off.
The arithmetic: 3 mL at 10 clicks is 30 draws. Daily, you use 28 of them inside the 4-week refrigerated window โ one vial per four weeks, almost nothing wasted. 8 weeks = 2 vials. 12 weeks = 3 vials. That's one syringe per day; the box includes 10, so add a syringe pack or use the pen.
Why 10 clicks, when many guides say 15
15 clicks gives the round 500 mcg of each repair peptide, and a lot of online protocols use it. But on this batch it also delivers about 3.2 mg of GHK-Cu a day โ above the 2 mg we publish for GHK-Cu on its own โ and about half a milligram of injected copper. 10 clicks lands at about 2.1 mg of GHK-Cu, in line with our GHK-Cu protocol.
If you want more repair, add BP-157 rather than turning up the copper. That's exactly what our Complete (KLOW) package does.
20 clicks: we don't recommend it. Over 4 mg of GHK-Cu a day, more sting, a vial every 15 days, and no evidence of better results.
The copper, in numbers
GHK-Cu is roughly 16% copper by weight. At 10 clicks from this batch you inject about 0.33 mg of copper a day. For scale, the adult recommended intake from food is 0.9 mg a day and the upper limit is 10 mg. It's small โ but injected copper bypasses the gut, which normally regulates how much copper gets in, and the liver has to clear it. That's why this protocol has off-cycles, why we don't escalate, and why anyone with a copper or liver disorder should not use it.
- 1ร KLOW Blend ยท 80 mg
- 10ร sterile insulin syringes (free)
- 1ร bacteriostatic water vial (free)
- Compound Guide โ printed, included free
No clinical trial exists for KLOW, GLOW, or any combination of these four peptides. Component by component: GHK-Cu has small human studies for topical skin use and none for injection; BPC-157 and TB-500 rest on animal and cell data (a 2025 review found 35 of 36 BPC-157 musculoskeletal studies were preclinical); KPV is cell and mouse data, almost all of it oral. KLOW is co-lyophilised at the factory as a single dry powder. How the four behave together once dissolved has not been published โ one more reason to finish each vial within its 4-week window.
Regulatory: not approved anywhere. In the US, BPC-157, TB-500 and KPV came off the FDA's 503A Category 2 list in April 2026, and an FDA advisory committee voted narrowly in July 2026 to recommend them for compounding. The draft HHS compounding policy of October 2026 covers single-ingredient products only โ and KPV only by mouth or on the skin, not by injection. Injectable GHK-Cu nominations were withdrawn and it is not on any FDA list. None of this is an approval.
Athletes: contains BPC-157 (WADA S0) and TB-500 (WADA S2). Prohibited at all times.
- Pickart & Margolina, Int J Mol Sci, 2018 โ GHK-Cu review: human data are small topical skin studies; no human injection trials
- Dalmasso et al., Gastroenterology, 2008 โ KPV blocked NF-ฮบB at nanomolar levels via PepT1; oral KPV reduced colitis in mice
- Kannengiesser et al., Inflamm Bowel Dis, 2008 โ KPV reduced inflammation in two mouse colitis models
- Vasireddi et al., HSS Journal, 2025 โ 35 of 36 BPC-157 musculoskeletal studies were preclinical
- Philp et al., Wound Repair Regen, 2003 โ the TB-500 sequence LKKTETQ promoted wound repair in aged mice
- Malinda et al., J Invest Dermatol, 1999 โ thymosin ฮฒ4 increased wound re-epithelialisation by 42โ61% in rats
- NIH Office of Dietary Supplements, Copper fact sheet โ adult RDA 900 mcg/day, upper limit 10 mg/day; Wilson's disease causes copper toxicity
- U.S. FDA, 503A bulk drug substances list, May 2026 โ injectable GHK-Cu nominations withdrawn
Every peptide batch we sell is tested by Janoshik Analytical, an independent laboratory. Every vial carries an internal AVERON batch code identifying the lot received; each lot is linked to its published Janoshik report. The report carries the manufacturer's submission/task number, not the AVERON code. Ask us or our driver which report covers your code and open it on the laboratory's own website before paying. In our own-driver zone, the team shows you the vial and the report for that batch before payment.
A lab report handed to you by a seller and a lab report you can verify yourself are not the same thing. That's why we publish ours.
View COA on JanoshikMore in Recovery & Resilience


Wolverine Blend
BPC-157 + TB-500 in one vial: local and systemic repair

GHK-Cu
Copper peptide for skin, hair and everyday support.







